We develop and improve biomedical imaging technologies to study cancer and autoimmune diseases with the goal of improving diagnosis and treatment outcomes. These tools allow us to observe and understand changes across a variety of disease models, ranging from the more experimentally accessible cell culture and animal models to clinical trials in patients. We take advantage of a broad spectrum of emerging optical imaging strategies available at Stanford University to perform cutting-edge research. Our lab research focuses on improving the quality of patient outcomes by improving cancer detection, understanding disease pathogenesis and progression, and developing data-driven hypotheses for downstream interrogation by more traditional methods.